step up trial semaglutide Top-line Results for 7.2 mg Novo Nordisk has shared results from the STEP UP trial evaluating semaglutide 7.2 mg for obesity treatment: πΉAverage weight loss of 20.7% with Finishing my 72-week clinical trial
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5



























